Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $0.331 $0.440 Thursday, 9th May 2024 GLMD stock ended at $0.415. This is 6.71% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 13.51% from a day low at $0.370 to a day high of $0.420.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
Nov 25, 2016 $3.72 $3.76 $3.53 $3.75 32 476
Nov 23, 2016 $3.66 $3.68 $3.37 $3.63 30 021
Nov 22, 2016 $3.99 $4.01 $3.63 $3.69 68 596
Nov 21, 2016 $4.20 $4.20 $3.63 $3.97 76 418
Nov 18, 2016 $3.61 $3.83 $3.61 $3.81 35 688
Nov 17, 2016 $3.70 $3.83 $3.62 $3.70 49 805
Nov 16, 2016 $3.97 $4.35 $3.61 $3.69 31 844
Nov 15, 2016 $3.86 $4.08 $3.60 $3.66 18 937
Nov 14, 2016 $3.50 $3.66 $3.50 $3.64 34 765
Nov 11, 2016 $3.40 $3.62 $3.40 $3.55 38 798
Nov 10, 2016 $3.52 $3.69 $3.24 $3.49 115 286
Nov 09, 2016 $3.45 $3.56 $3.05 $3.27 160 585
Nov 08, 2016 $3.42 $3.44 $3.19 $3.43 76 819
Nov 07, 2016 $3.20 $3.43 $3.09 $3.19 71 500
Nov 04, 2016 $2.95 $3.13 $2.78 $3.08 38 100
Nov 03, 2016 $3.13 $3.13 $2.80 $2.85 82 200
Nov 02, 2016 $3.26 $3.40 $2.82 $3.06 186 900
Nov 01, 2016 $3.44 $3.59 $3.07 $3.19 431 600
Oct 31, 2016 $3.50 $3.54 $3.25 $3.40 34 500
Oct 28, 2016 $3.66 $3.69 $3.42 $3.59 59 300
Oct 27, 2016 $3.71 $3.83 $3.61 $3.62 30 400
Oct 26, 2016 $3.75 $4.08 $3.62 $3.69 23 200
Oct 25, 2016 $3.95 $4.17 $3.75 $3.75 95 600
Oct 24, 2016 $3.94 $4.01 $3.73 $3.97 56 500
Oct 21, 2016 $3.98 $4.00 $3.77 $3.88 55 900
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT